Table 4 Results of multivariate analyses of disease-free survival and overall survival
From: Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study
Disease-free survival | Overall survival | |||||
|---|---|---|---|---|---|---|
Hazard ratio | 95 % CI | P value | Hazard ratio | 95 % CI | P value | |
Age (<40 vs. ≥ 40) | 1.0 | 0.8–1.2 | 0.67 | 1.0 | 0.8–1.2 | 0.61 |
Stage (I/II vs. III/IV) | 0.9 | 0.9–1.0 | 0.39 | 0.9 | 0.9–1.0 | 0.86 |
Radical surgery | 1.0 | 0.9–1.0 | 0.25 | 1.0 | 0.9–1.0 | 0.64 |
Staging surgery | 1.0 | 0.9–1.0 | 0.10 | 1.0 | 0.9–1.1 | 0.052 |
Menopause | 0.9 | 0.8–1.2 | 0.95 | 1.0 | 0.8–1.3 | 0.57 |
Invasive implant | 0.8 | 0.6–1.2 | 0.47 | 0.8 | 0.6–1.2 | 0.51 |
Lymph node dissection | 0.9 | 0.9–1.1 | 0.08 | 0.8 | 0.7–1.1 | 0.08 |
Adjuvant chemotherapy (tumorstage ≥ IC) | 0.8 | 0.6–1.0 | 0.06 | 0.9 | 0.8–1.1 | 0.07 |